Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: A report from the National Wilms' Tumor Study Group

Journal of Clinical Oncology

Volumn 22, Issue 3, 2004, Pages 468-473

  Seibel, Nita L ^a   Li, Sierra ^b   Breslow, Norman E ^b   Beckwith, J Bruce ^b   Green, Daniel M ^b   Haase, Gerald M ^b   Ritchey, Michael L ^b   Thomas, Patrick R M ^b   Grundy, Paul E ^b   Finklestein, Jerry Z ^b   Kim, Tae ^b   Shochat, Stephen J ^b   Kelalis, Panayotis P ^b   D'Angio, Giulio J ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; KIDNEY SARCOMA; NEPHROBLASTOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; ADULT; CANCER STAGING; CLEAR CELL SARCOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; KIDNEY TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TIME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DACTINOMYCIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SARCOMA, CLEAR CELL; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VINCRISTINE;

EID: 1442314932     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.06.058     Document Type: Article

References (16)

1. Kidd JM: Exclusion of certain renal neoplasms from the category of Wilms tumor. Am J Pathol M58:16a, 1970 (abstr)
2. Morgan E, Kidd JM: Undifferentiated sarcoma of the kidney: A tumor of childhood with histopathologic and clinical characteristics distinct from Wilms tumor. Cancer 42:1916-1921, 1978
3. Beckwith JB, Palmer NF: Histopathology and prognosis of Wilms tumor: Results of the first National Wilms Tumor Study. Cancer 41: 1937-1948, 1978
4. Marsden HB, Lawler W: Bone-metastasizing renal tumor of childhood. Br J Cancer 38:437-441, 1978
5. Green DM, Breslow NE, Beckwith JB, et al: The treatment of children with clear-cell sarcoma of the kidney: A report from the National Wilms' Tumor Study Group. J Clin Oncol 12: 2132-2137, 1994
6. Green DM, Breslow NE, Beckwith JB, et al: Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 16:237-245, 1998
7. Green DM, Breslow NE, Evans I, et al: The effect of chemotherapy dose-intensity on the hematological toxicity of the treatment for Wilms' tumor: A report from the National Wilms' Tumor Study. Am J Pediatr Hematol Oncol 16: 207-212, 1994
8. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 33:457-481, 1958
9. Peto B, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135:185-206, 1972
10. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
11. Green DM, Breslow NE, Beckwith JB, et al: Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 16:3744-3751, 1998
12. Argani P, Perlman EJ, Breslow NE, et al: Clear cell sarcoma of the kidney: A review of 351 cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol 24:4-18, 2000
13. Green DM, Grigorien YA, Nan B, et al: Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 19:1926-1934, 2001
14. Mitchell C, Jones PM, Kelsy A, et al: The treatment of Wilms' tumour: Results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study. Br J Cancer 83:602-608, 2000
15. Tournade M, Com-Nougué C, de Kraker J, et al: Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: Results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 19:488-500, 2001
16. Bonnin JM, Rubinstein LJ, Palmer NF, et al: The association of embryonal tumors originating in the kidney and in the brain: A report of seven cases. Cancer 54:2137-2146, 1984